DONNATAL EXTENTABS SRT
DONNATAL EXTENTABS SRT
Discontinued
DIN Number
02042908
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
wyeth-ayerst canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02042908
AIG Number0404677002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
A03ED ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification12:08.08
Health Canada Classification
ACTIVE INGREDIENTS (4)
ATROPINE SULFATEActive
Strength: 0.0582 MG / SRT
Monograph: ATROPINE SULFATE
HYOSCYAMINE SULFATEActive
Strength: 0.3111 MG / SRT
Monograph: HYOSCYAMINE SULFATE
PHENOBARBITALActive
Strength: 48.6 MG / SRT
Monograph: PHENOBARBITAL
SCOPOLAMINE HYDROBROMIDEActive
Strength: 0.0195 MG / SRT
Monograph: SCOPOLAMINE HYDROBROMIDE